Taiwan's Formosa Pharma and Singapore Eye Research Institute partner to advance novel ophthalmic formulations for corneal diseases

Singapore, May 1 -- Taiwan-based Formosa Pharmaceuticals, Inc. and the Singapore Eye Research Institute (SERI) have annoounced a strategic research collaboration to develop next-generation ophthalmic ... Read More

Japan's Shionogi joins World Economic Forum and signs Davos Compact on Antimicrobial Resistance

Singapore, May 1 -- Japan-based Shionogi & Co. has joined the World Economic Forum (WEF), and signed the Davos Compact on Antimicrobial Resistance (AMR). The World Economic Forum, established in 1971... Read More

Ecolab Life Sciences expands global bioprocessing capabilities with new centre in Korea

Singapore, April 30 -- Ecolab Life Sciences is expanding the bioprocessing business with the launch of a new Bioprocessing Applications Lab (BPAL) in Dongtan, Korea, giving biopharmaceutical manufactu... Read More

Emirates Drug Establishment gives nod to first nasal epinephrine spray

Singapore, April 30 -- The Emirates Drug Establishment (EDE) has officially granted approval for EURneffy(R), a novel epinephrine-based treatment available in 1 mg and 2 mg strengths, making the UAE t... Read More

Japan's Shimadzu acquires majority stake in German startup Plasmion

Singapore, April 30 -- Japan-based Shimadzu Corporation has acquired a 75% stake of the outstanding shares of German startup Plasmion GmbH (headquartered in Augsburg, Bavaria), making the company a su... Read More

Ravidasvir receives approval in Thailand for treatment of Hepatitis C

Singapore, April 30 -- In a historic step for the Egyptian pharmaceutical industry that reinforces its global leadership, the Thai Food and Drug Administration (Thai FDA) has officially approved Ravid... Read More

Australia eliminates trachoma as public health problem

Singapore, April 30 -- The World Health Organization (WHO) has validated Australia for eliminating trachoma as a public health problem, marking a significant milestone in the health of Indigenous peop... Read More

China gives marketing approval to world's first recombinant Botulinum Toxin Type A drug

Singapore, April 29 -- Chongqing Claruvis Pharmaceutical, a subsidiary of MingMed Biotechnology, has announced that the China's National Medical Products Administration (NMPA) has approved its Re... Read More

Arcera Life Sciences inks long-term collaboration framework with Fosun Pharma

Singapore, April 29 -- Arcera Life Sciences, a global life sciences company headquartered in Abu Dhabi, and Shanghai Fosun Pharmaceutical Group, an innovation-driven global pharmaceutical and healthca... Read More

NUS scientists engineer bacteria to treat severe liver-related brain dysfunction

Singapore, April 29 -- When the liver fails, toxins - such as ammonia - that should be filtered from the blood build up and reach the brain. The result is hepatic encephalopathy (HE), a devastating ne... Read More

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»